Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression Anastomosis
- Status
- COMPLETED
- Phase
- N/A
AMG 319 Lymphoid Malignancy FIH
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediatric Patients With Solid Tumors and Leukemias
- Status
- COMPLETED
- Phase
- PHASE1
Study of Carfilzomib and Vorinostat for Relapsed or Refractory Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy
- Status
- TERMINATED
- Phase
- PHASE2
A Study of MK-4827 for the Treatment of Mantle Cell Lymphoma (MK-4827-002)
- Status
- WITHDRAWN
- Phase
- PHASE2
An Early Phase I Study of IPdR Absorption, Metabolism, and Safety in Patients With Advanced Solid Tumors and Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers
- Status
- UNKNOWN
- Phase
- PHASE2
Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab Maintenance Therapy for Marginal Zone B-cell Lymphoma (MZL)
- Status
- COMPLETED
- Phase
- PHASE2
Incidence of Hepatitis B Virus (HBV) Reactivation in HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOP
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2
- Status
- COMPLETED
- Phase
- PHASE2